Steve Cohen rated Cogent Biosciences as a buy, coinciding with Citibank raising its price target on the stock.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Steve Cohen rated Cogent Biosciences as a buy, coinciding with Citibank raising its price target on the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cogent Biosciences (United States)
company in Waltham, United States
Nothing else this week.
-
Citibank
American multinational bank
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyCogent Biosciences Rated as a Buy at Citi on Robust Pipeline Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 18, Citi rai